BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Falls KC, Sharma RA, Lawrence YR, Amos RA, Advani SJ, Ahmed MM, Vikram B, Coleman CN, Prasanna PG. Radiation-Drug Combinations to Improve Clinical Outcomes and Reduce Normal Tissue Toxicities: Current Challenges and New Approaches: Report of the Symposium Held at the 63rd Annual Meeting of the Radiation Research Society, 15-18 October 2017; Cancun, Mexico. Radiat Res 2018;190:350-60. [PMID: 30280985 DOI: 10.1667/RR15121.1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Beltran C, Amos RA, Rong Y. We are ready for clinical implementation of Carbon Ion Radiotherapy in the United States. J Appl Clin Med Phys 2020;21:6-9. [PMID: 33319499 DOI: 10.1002/acm2.13133] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Reda M, Bagley AF, Zaidan HY, Yantasee W. Augmenting the therapeutic window of radiotherapy: A perspective on molecularly targeted therapies and nanomaterials. Radiother Oncol 2020;150:225-35. [PMID: 32598976 DOI: 10.1016/j.radonc.2020.06.041] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Xu W, Huang SH, Su J, Gudi S, O'Sullivan B. Statistical fundamentals on cancer research for clinicians: Working with your statisticians. Clin Transl Radiat Oncol 2021;27:75-84. [PMID: 33532634 DOI: 10.1016/j.ctro.2021.01.006] [Reference Citation Analysis]
4 Zakeri K, Narayanan D, Prasanna PGS, Vikram B, Buchsbaum JC. Development of Novel Radiosensitizers through the National Cancer Institute's Small Business Innovation Research Program. Radiat Res 2020;193:425-34. [PMID: 32216707 DOI: 10.1667/RR15545.1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
5 Hingorani DV, Crisp JL, Doan MK, Camargo MF, Quraishi MA, Aguilera J, Gilardi M, Gross LA, Jiang T, Li WT, Ongkeko WM, Cohen EEW, Gutkind JS, Adams SR, Advani SJ. Redirecting extracellular proteases to molecularly guide radiosensitizing drugs to tumors. Biomaterials 2020;248:120032. [PMID: 32304937 DOI: 10.1016/j.biomaterials.2020.120032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
6 Hingorani DV, Doan MK, Camargo MF, Aguilera J, Song SM, Pizzo D, Scanderbeg DJ, Cohen EEW, Lowy AM, Adams SR, Advani SJ. Precision Chemoradiotherapy for HER2 Tumors Using Antibody Conjugates of an Auristatin Derivative with Reduced Cell Permeability. Mol Cancer Ther 2020;19:157-67. [PMID: 31597712 DOI: 10.1158/1535-7163.MCT-18-1302] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
7 Khan MK, Nasti TH, Buchwald ZS, Weichselbaum RR, Kron SJ. Repurposing Drugs for Cancer Radiotherapy: Early Successes and Emerging Opportunities. Cancer J 2019;25:106-15. [PMID: 30896532 DOI: 10.1097/PPO.0000000000000369] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Prasanna PG, Rawojc K, Guha C, Buchsbaum JC, Miszczyk JU, Coleman CN. Normal Tissue Injury Induced by Photon and Proton Therapies: Gaps and Opportunities. Int J Radiat Oncol Biol Phys 2021;110:1325-40. [PMID: 33640423 DOI: 10.1016/j.ijrobp.2021.02.043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Ruan JL, Browning RJ, Yildiz YO, Gray M, Bau L, Kamila S, Thompson J, Elliott A, Smart S, McHale AP, Callan JF, Vojnovic B, Stride E, Kiltie AE. Ultrasound-Mediated Gemcitabine Delivery Reduces the Normal-Tissue Toxicity of Chemoradiation Therapy in a Muscle-Invasive Bladder Cancer Model. Int J Radiat Oncol Biol Phys 2021;109:1472-82. [PMID: 33714528 DOI: 10.1016/j.ijrobp.2020.11.046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]